Clinical trials are using AI to handle large and complex volumes of categorized and uncategorized data in multi-center clinical trials to develop oncology, cardiovascular, and neurologic compounds and to integrate molecular and imaging data This technology can improve the efficiency of patient recruitment, protocol design, patient monitoring, data analysis, new target discovery, and overall chances that trials will yield valuable data. AI can also detect minute anomalies reducing false negatives in clinical trials, which is especially beneficial with drugs like targeted oncologic agents.